The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $4.67

Today's change+0.09 +1.97%
Updated September 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $4.67

Today's change+0.09 +1.97%
Updated September 30 4:00 PM EDT. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc up sharply

Spectrum Pharmaceuticals Inc closed up sharply Friday, rallying (U.S.)$0.09 or 1.97% to (U.S.)$4.67. Over the last five days, shares have lost 1.06% and are down 22.55% for the last year to date. This security has underperformed the S&P 500 by 34.84% during the last year.

Key company metrics

  • Open(U.S.) $4.60
  • Previous close(U.S.) $4.58
  • High(U.S.) $4.71
  • Low(U.S.) $4.55
  • Bid / Ask(U.S.) $0.00 / (U.S.) $7.50
  • YTD % change-22.55%
  • Volume469,146
  • Average volume (10-day)970,455
  • Average volume (1-month)988,774
  • Average volume (3-month)856,959
  • 52-week range(U.S.) $4.14 to (U.S.) $7.74
  • Beta1.49
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.85
Updated September 30 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.19%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue34445029
Total other revenue--------
Total revenue34445029
Gross profit26374420
Total cost of revenue8768
Total operating expense56505345
Selling / general / administrative28222119
Research & development14151510
Depreciation / amortization66107
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-22-6-3-16
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-24-9-4-19
Income after tax-24-9-4-19
Income tax, total0000
Net income-24-9-4-19
Total adjustments to net income--------
Net income before extra. items-24-9-4-19
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-24-9-4-19
Inc. avail. to common incl. extra. items-24-9-4-19
Diluted net income-24-9-4-19
Dilution adjustment--------
Diluted weighted average shares69666366
Diluted EPS excluding extraordinary itemsvalue per share-0.35-0.14-0.07-0.28
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.35-0.14-0.07-0.28